Tenaris S.A. Form 6-K Summary
Business Context and Reporting Period
This filing reports the resolutions adopted at the Extraordinary General Meeting of Shareholders held on May 12, 2026, immediately following the Annual General Meeting. The Company is a foreign private issuer headquartered in Luxembourg.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on capital structure adjustments.
- Share Buyback Program: The third share buyback program ran from June 9, 2025, to March 3, 2026.
- Shares Cancelled: 62,355,174 ordinary shares held in treasury were cancelled.
- Capital Reduction: Issued share capital was reduced by US$62,355,174.
- Post-Reduction Capital: US$1,009,639,756 represented by 1,009,639,756 ordinary shares (US$1.00 nominal value per share).
- Authorized Capital: Remains at US$2,500,000,000.
Material Changes
The primary material change is the reduction of issued share capital and the corresponding decrease in the number of outstanding shares following the completion of the third buyback program. The Company's Articles of Association were amended to reflect these changes.
Guidance, Outlook, and Corporate Actions
The filing details the amendment of Article 5 of the Articles of Association regarding share capital. Key provisions include:
- Board Authority: The Board of Directors is authorized to issue shares within the authorized capital limit for a period of five years from May 6, 2025.
- Pre-emptive Rights: General waiver of pre-emptive subscription rights for cash issuances, subject to specific exceptions.
- Exceptions to Waiver: Pre-emptive rights apply unless the issuance is for non-cash contributions or for employee compensation/incentives up to 1.5% of issued share capital.
- Debt Instruments: The Board retains the authority to authorize the issuance of convertible bonds.
Investor Verification Checklist
- Verify the exact number of shares cancelled (62,355,174) and the resulting total share count (1,009,639,756).
- Confirm the reduction in issued share capital from US$1,071,994,930 to US$1,009,639,756.
- Review the specific terms of the Board's authority to issue shares without pre-emptive rights for the next five years.
- Note that this filing contains no operational financial results; refer to the Annual Report (Form 20-F) for performance metrics.